Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Neurobiol Dis. 2011 Jun 25;44(1):73–83. doi: 10.1016/j.nbd.2011.06.006

Figure 7. AAV-Netrin-1 gene therapy does not significantly reduce the size of ischemic infarct.

Figure 7

AAV-Netrin1 or AAV-LacZ was delivered at one hour following MCAO and the infarct volume was determined at 8 weeks following gene transfer. A, Although rats that received AAV-Netrin-1 gene therapy in general had a smaller infarct volume as compared to those that received AAV-LacZ, the difference was not statistically significant (p=0.22). B, Representative images of NeuN stained coronal sections showing the regions of infarct.